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Abstract
Studies on human intestinal injury induced by acute exposure to γ-radiation commonly rely on use of animal models
because culture systems do not faithfully mimic human intestinal physiology. Here we used a human Gut-on-a-Chip
(Gut Chip) microﬂuidic device lined by human intestinal epithelial cells and vascular endothelial cells to model
radiation injury and assess the efﬁcacy of radiation countermeasure drugs in vitro. Exposure of the Gut Chip to γ-
radiation resulted in increased generation of reactive oxygen species, cytotoxicity, apoptosis, and DNA fragmentation,
as well as villus blunting, disruption of tight junctions, and compromise of intestinal barrier integrity. In contrast, pre-
treatment with a potential prophylactic radiation countermeasure drug, dimethyloxaloylglycine (DMOG), signiﬁcantly
suppressed all of these injury responses. Thus, the human Gut Chip may serve as an in vitro platform for studying
radiation-induced cell death and associate gastrointestinal acute syndrome, in addition to screening of novel radio-
protective medical countermeasure drugs.
Exposure to ionizing γ-radiation, whether therapeutic or
accidental, may result in acute radiation syndrome that is
associated with gastrointestinal (GI) disturbances leading
to massive shortening or “blunting” of intestinal villi,
disruption of tight junctions, increased apoptosis within
the microvascular endothelium, mucosal barrier break-
down, inﬂammation, abdominal pain, diarrhea, and
vomiting, which can result in intestinal hemorrhage,
sepsis, and death1–4. Development of medical counter-
measures (MCMs) to protect against the devastating
effects of radiation is therefore of tremendous importance.
Animal models have been primarily used for GI radiation
research because they can mimic some of the clinical
manifestations of radiation poisoning (e.g., vomiting,
diarrhea), however, these in vivo models often fail to
effectively mimic cellular mechanisms of radiation toxi-
cities or drug mechanisms of action displayed in
humans5,6. Ethical issues related to animal testing also
present a considerable hurdle, particularly when it relates
to studies on primates7. As a result, the mechanisms
underlying the radiation-induced GI syndrome remain
unclear, and this represents a major challenge with
regards to discovery of new MCMs8,9.
Understanding of radiation-induced intestinal injury
could be greatly facilitated by the availability of experi-
mental in vitro models that recapitulate human cell and
tissue responses to radiation; unfortunately, this has not
been possible using existing culture systems. In particular,
the 3D villus architecture and differentiated barrier
functions of the intestine are known to contribute greatly
to intestinal tissue responses to radiation. It is likely for
this reason that past efforts, for example, using Transwell
culture systems lined by human Caco-2 intestinal
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epithelial cells that grow as a ﬂat monolayer failed to
model radiation injury8,10,11. Furthermore, past in vitro
models used to study intestinal responses to radiation did
not incorporate a human vascular endothelium in the
vicinity of the intestinal epithelium to mimic capillary
blood vessels, which are situated very close to epithelial
cells in the gut mucosa11. This is important because while
intestinal stem cells have always been assumed to be the
major mediator of radiation damage involved in devel-
opment of the GI syndrome12,13, recent studies suggest
that apoptosis within the microvascular endothelium may
be a key mediator of radiation damage that, in turn, leads
to stem cell dysfunction14–16.
To model radiation-induced damage in vitro, we adap-
ted a recently described human Gut-on-a-Chip (Gut
Chip) microﬂuidic culture device that is lined by human
intestinal epithelium interfaced with a human vascular
endothelium, which spontaneously differentiates and
forms three-dimensional intestinal villi when cultured in
the presence of ﬂow and cyclic peristalsis-like deforma-
tions10,17,18. Here we show that this microﬂuidic human
Gut Chip can be used to analyze the effects of γ-radiation
on villus morphology, barrier function, cell–cell junctions,
cellular toxicity, apoptosis, reactive oxygen species (ROS)
generation, and DNA fragmentation in vitro. We also
demonstrate that it can be used as a tool to evaluate the
radiation-protecting effects of a potential radiation
countermeasure drug, the small-molecule prolylhydrox-
ylase inhibitor dimethyloxalylglycine (DMOG), which has
been reported to protect small intestine against radiation
Fig. 1 Human Gut Chip microﬂuidic culture device. a Schematic showing the positions of the human intestinal epithelium and endothelium
when initially plated on opposite sides of the matrix-coated porous membrane within the two-channel microﬂuidic device (left), and how this
progresses to form a villus epithelium in the top channel interfaced with a planar endothelium that forms a lumen in the bottom channel (middle). A
representative immunoﬂuorescence confocal micrograph visualizing a cross-section of the Gut Chip device with the villus intestinal epithelium
stained for villin (green) to visualize the apical brush border, and the planar endothelium stained for VE-cadherin (red) to visualize adherens junctions,
is shown at the right (bar, 100 μm). b Microscopic views showing the villus morphology of the human Caco-2 intestinal epithelium cultured for about
5 days in the Gut Chip with ﬂow (30 μl h−1) and cyclic strain (10% at 0.15 Hz), when viewed from above by DIC imaging (left; bar, 50 μm) or by
immunoﬂuorescence staining for the tight junction protein, ZO-1 (green, middle; bar, 50 μm) and villin (green, right; bar, 100 μm). Blue and gray
indicate DAPI-stained nuclei. c Microscopic views showing the planar morphology of the human endothelium cultured under identical conditions as
in b, when viewed from above by phase contrast imaging (left; bar, 50 μm) or immunoﬂuorescence staining for the endothelial cell junction-
associated proteins PECAM-1 (green, middle; bar, 50 μm) and VE-cadherin (red, right; bar, 200 μm). Blue indicates DAPI-stained nuclei
Jalili-Firoozinezhad et al. Cell Death and Disease  (2018) 9:223 Page 2 of 14
Ofﬁcial journal of the Cell Death Differentiation Association
damage by stabilizing hypoxia-inducible factor 1α and 2α
(HIF-1α and HIF-2α)19.
Results
Establishing a human gut radiation injury model in vitro
The microﬂuidic human Gut Chip is a microﬂuidic
culture device composed of a clear, ﬂexible, poly-
dimethylsiloxane (PDMS) polymer, which contains two
parallel microchannels separated by a porous, ﬂexible,
extracellular matrix (ECM)-coated membrane lined by
human Caco-2 intestinal epithelial cells on one side and
human umbilical vein microvascular endothelial cells on
the other (Fig. 1a, left). Medium is perfused through both
channels (30 μl h-1; 0.02 dyne cm−2) and cyclic
deformations (0.15 Hz; 10% strain) similar to those
experienced by cells within the intestine during peri-
stalsis20 are induced by applying cyclic suction through
hollow side chambers (Supplementary Fig. S1a), as pre-
viously described10,17,18. When Caco-2 intestinal epithelial
cells are cultured under these conditions, they undergo
villus differentiation and express multiple features of
human small intestine within 5–7 days when analyzed at
the molecular, morphological, physiological, and tran-
scriptomic levels10,17,18, even though the same cells in the
same medium fail to undergo signiﬁcant differentiation in
Transwell cultures10. In contrast to past Gut Chip studies,
we cultured endothelial cells on all four sides of the lower
channel to engineer a hollow endothelium-lined vascular
Fig. 2 Radiation-induced apoptosis and cytotoxicity in intestinal epithelium and vascular endothelium, and radio-protective effects of
DMOG. a Representative immunoﬂuorescence micrographs of TUNEL (red) and DAPI (white) staining in epithelial and endothelial cells cultured on-
chip in the absence (Con) or presence (Rad) of 8 Gy of γ-radiation (Rad), with or without DMOG treatment, 24 h and 48 h after radiation exposure (bar,
50 μm). b Graph showing the quantiﬁcation of the percentage of epithelium and endothelium cells that expressed TUNEL staining (TUNEL+ cells) 24
h and 48 h after exposure to the conditions shown in a (n = 3; *P < 0.05, **P < 0.01, ***P < 0.001). c Graph showing radiation-induced cell death in the
epithelium (left) and endothelium (right) in the absence (Rad) or presence of DMOG (DMOG + Rad), as assessed by quantifying LDH release from cells
(data are presented as fold change in LDH levels relative to the non-irradiated control cells; n = 3; *P < 0.05,
**P < 0.01, ***P < 0.001)
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lumen in these devices (Fig. 1a, middle). Differential
interference contrast (DIC) and immunoﬂuorescence
microscopic analysis conﬁrmed that the Caco-2 cells
formed a villus intestinal epithelium with polarized epi-
thelial cells lined by ZO-1-containing tight junctions and
an apical villin-containing brush border (Fig. 1b;
Fig. 3 (See legend on next page.)
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Supplementary Fig. S1b). In the lower channel, endothe-
lial cells grew to form a conﬂuent cell monolayer joined
by CD31-containing adherens junctions, which covered
all four sides of the channel surrounding the hollow
vascular lumen (Fig. 1a, right; Fig. 1c; Supplementary
Fig. S1b).
We then exposed the human gut chips to γ-radiation.
Previous studies have shown that exposure to a level of
~4-8 gray (Gy) of γ-radiation can lead to GI syndrome and
death in the absence of treatment in humans13,21. Rodents
subjected to total body irradiation at a dose of 8 Gy also
show progressive intestinal injury with increased number
of apoptotic and mitotic cells, as well as shortening of the
villi22,23. Exposure of the human gut chips to 8 Gy γ-
radiation for 24 h similarly resulted in signiﬁcant increases
in apoptosis within both epithelium and endothelium
compared to non-irradiated control chips, however, the
number of apoptotic endothelial cells was about ﬁvefold
higher in the endothelium at this time (Fig. 2a,b). Inter-
estingly, the epithelium appeared to undergo a distinct
and slower mechanism of apoptosis induction as the
apoptosis labeling index increased signiﬁcantly 48 h after
radiation exposure, whereas the endothelial apoptosis
index was maximal at day 1 (Fig. 2a,b). In contrast, both
the epithelium and endothelium exhibited similar levels of
cell membrane damage at 24 h, as measured by quanti-
fying extracellular release of the intracellular enzyme,
lactate dehydrogenase (LDH), and these levels remained
high for at least 72 h after radiation exposure (Fig. 2c).
Control studies also conﬁrmed that direct exposure of the
chip without cells did not induce cytotoxicity when cells
were then cultured on these devices (Supplementary
Fig. S2), conﬁrming that cell injury was not caused by
radiation-induced release of toxins from the PDMS
material.
As ROS are critical mediators of radiation-induced
damage that have been reported to play a pivotal role in
intestinal epithelial injury as well as epithelial and endo-
thelial apoptosis in patients24–26, we sought to determine
if radiation induces ROS formation in the human Gut
Chip. Quantiﬁcation of ROS production using CellROX
Green Reagent revealed that endothelial cells generated
about twice the level of ROS per cell compared to the
intestinal epithelial cells (approximately eightfold versus
fourfold increases, respectively) (Fig. 3a,b). Lipids are one
of the main targets attacked by ROS, and this results in
lipid peroxidation and cell membrane damage27–29. Con-
sistent with this observation and our ROS results, the level
of lipid peroxidation after radiation was again almost two
times higher in the endothelium compared to the epi-
thelium (Fig. 3c,d).
Ionizing radiation is thought to produce many of its
damaging effects on cells by producing clustered DNA
double-strand breaks (DSB), promoting hyperpho-
sphorylation of DSB-associated proteins, and inducing
formation of discrete nuclear foci containing p53-binding
protein 1 (53BP1), an important regulator of DSB sig-
naling that is regulated by γ-radiation30–32. Similarly, we
found that while 53BP1 was diffusely localized in the
nuclei of control intestinal epithelial and endothelial cells
in the Gut Chip, it relocated to punctate nuclear foci
within both cell types when they were irradiated (Fig. 3e,
f). Again, while more than 95% of endothelial cells
exhibited discrete nuclear foci formation, the intestinal
epithelial cells only exhibited about half this level of
response. These ﬁndings appear to be consistent with past
studies that suggested radiation-induced epithelial cell
injury and DNA damage are mediated by endothelial
apoptosis and ROS generation which are upstream from
the epithelial cell injury responses15,33–35.
Recapitulating intestinal organ-level radiation-induced
injury
The small intestines of patients exposed to high levels of
γ-radiation exhibit characteristic morphological changes
including decreased villi height and irregular, shortened
microvilli (“villus blunting”), as well as cytoplasmic vacuo-
lization and detachment of epithelial and endothelial cells
(see ﬁgure on previous page)
Fig. 3 Radiation-induced changes in ROS, lipid peroxidation and DNA fragmentation in the presence or absence of DMOG treatment. a
Radiation-induced changes in intracellular ROS in the intestinal epithelium (top) and endothelium (bottom) measured 30 min after exposure to γ-
radiation (8 Gy) in the absence (Rad) or presence of DMOG (DMOG + Rad), or under control non-radiated conditions (Con), as visualized using the
CellROX Green Reagent (green) (blue, DAPI-stained nuclei; bar, 50 μm). b Quantiﬁcation of ROS production measured under the conditions described
in a, expressed as fold change relative to non-irradiated control cells (n = 3; *P < 0.05, ***P < 0.001). c Radiation-induced changes in lipid peroxidation
in the intestinal epithelium (top) and endothelium (bottom) measured under the same conditions as shown in a, detected using an Image-iT® Lipid
Peroxidation Kit in which lipid peroxidation results in a shift of ﬂuorescence emission from 510 nm (red) to 590 nm (green) (blue indicated DAPI-
stained nuclei; bar, 50 μm). d Quantiﬁcation of lipid peroxidation measured under the conditions described in c. Data are presented as a shift the ratio
of the ﬂuorescence emission peak from 510 nm to 590 nm (n = 3; *P < 0.05, **P < 0.01, ***P < 0.001). e Effect of radiation on formation of DNA double-
strand breaks, as detected by increased punctate staining of 53BP1-positive (53BP1+) nuclei (green); nuclei were counterstained with DAPI (white)
(bar, 20 μm). White arrowheads indicate nuclei that display discrete punctate patterns of 53BP1+ staining. f Quantiﬁcation of the ratio of nuclei that
exhibited 53BP1+ punctate staining relative to total nuclei measured under the conditions described in e (n = 5; *P < 0.05, **P < 0.01, ***P < 0.001)
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from their basement membrane36–39. Similarly, we found
that exposure of the Gut Chips to 8 Gy resulted in loss of
normal villus architecture and disruption of epithelial and
endothelial integrity within 48 h. Computerized image
analysis of cross-sectional immunoﬂuorescence views of
villin-stained epithelium (Fig. 4a) revealed a signiﬁcant
reduction in the average height of villi in irradiated versus
control chips (68.2± 11.3 vs. 160.4± 19.6 μm, respectively)
(Fig. 4b). Moreover, while the heights of the majority of the
ﬁnger-like villi in control (non-irradiated) chips ranged
Fig. 4 Morphological analysis of intestinal villus damage induced by radiation exposure. a Representative vertical cross-sectional, confocal,
micrographic views through the intestinal epithelium-porous membrane-endothelium interface of the Gut Chip at 48 h before (Con) or after
exposure to γ-radiation (8 Gy) in the absence (Rad) or presence of DMOG pre-treatment (DMOG + Rad), when immunostained for villin (green) and
nuclei with DAPI (blue) (parallel white-dashed lines indicate upper and lower surfaces of the porous matrix-coated membrane; bar, 100 μm). b
Quantiﬁcation of intestinal injury evaluated by measuring changes in the height of the villi (n = 50) under control conditions (Con) versus after
exposure to γ-radiation (8 Gy) in the absence (Rad) or presence of DMOG pre-treatment (DMOG + Rad) (*P < 0.05, **P < 0.01). c Distribution of villus
heights measured under the conditions described in b. d Changes in apparent paracellular permeability (Papp) measured by quantitating cascade
blue transport across the tissue-tissue interface within the Gut Chip microdevices before (Con) or after radiation in the absence (Rad) or presence of
DMOG pre-treatment (DMOG + Rad) (n = 3; *P < 0.05, ***P < 0.001). e DIC (top; bar, 50 μm) views of the intestinal villi and SEM micrographs (bottom;
low magniﬁcation bar, 10 μm; high magniﬁcation inset bar, 1 μm) of the intestinal microvilli formed on-chip under control conditions (Con) or after
radiation exposure without (Rad) or with DMOG pre-treatment (DMOG + Rad)
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between 100 and 200 μm, <35% of villus structures in the
irradiated chip reached 100 μm or above (Fig. 4a,c). In
addition, scanning electron microscopic (SEM) analyses
showed that the apical surface of the irradiated epithelial
cells had very short and irregular microvilli compared to
control samples, making it difﬁcult to identify cell bound-
aries in the irradiated epithelium (Fig. 4e). When we ana-
lyzed the expression of the cell–cell junction proteins, ZO-
1 and VE-cadherin, in the irradiated epithelial and endo-
thelial cells, respectively, we observed decreased expression
of both molecules and a loss of junctional continuity in the
cell layers (Fig. 5a-c). Radiation exposure also resulted in
cell detachment and generation of cell-free gaps in the
endothelial monolayer.
Radiation injury of intestinal villi in humans is also
accompanied by breakdown of the intestinal mucosal
barrier, which can release bacteria and their toxins
through the intestinal wall, leading to further abdominal
complications40–42. When we evaluated the effect of
radiation on intestinal barrier function and mucosal
Fig. 5 Radiation-induced loss of junctional continuity and mucosal damage and the effects of DMOG pre-treatment. a Confocal
immunoﬂuorescence micrographs showing horizontal views through the mid-section of villi (100 μm above the porous membrane) stained for
epithelial tight junctions (ZO-1, red) at the top (bar, 100 μm), and through the middle of the endothelium stained for adherens junctions (VE-cadherin,
red) at the bottom (bar, 20 μm), within non-irradiated Gut Chips (Con) versus Gut Chips exposed to 8 Gy γ-radiation for 48 h without (Rad) or with
DMOG pre-treatment (DMOG + Rad). Quantiﬁcation of ﬂuorescence intensities (a.u.) of (b) ZO-1 and (c) VE-cadherin normalized per cell number (n =
3; *P < 0.05, **P < 0.01; n.s. not signiﬁcant)
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damage by measuring changes in the apparent perme-
ability coefﬁcient (Papp), which is a measure of paracellular
barrier function in the human Gut Chip, we observed a
fourfold increase in Papp (4.9× 10
−7 vs. 1.2× 10−7 cm
s−1) at 24 h after exposure when signiﬁcant apoptosis was
detected in the endothelial cells, and Papp almost doubled
again (8.7× 10−7 cm s−1) by 48 h (Fig. 4d). This was also
accompanied by signiﬁcant loss of expression of the
mucin protein, MUC2 (Fig. 6c,d), which is the most
abundant mucin secreted by goblet cells that plays a
pivotal role in organizing the intestinal mucus layers and
barrier integrity at the epithelial apical surface43,44.
Importantly, the suppression of MUC2 levels we detected
on-chip is similar to what is observed in irradiated
intestinal tissue in vivo45. Thus, the Gut Chip faithfully
mimics many facets of the human intestinal injury
response to radiation in vitro.
Endothelial cells as mediators of radiation damage
To conﬁrm whether vascular endothelium contributes
to radiation-induced intestinal epithelium damage, we
irradiated the Gut Chips in the absence or presence of
endothelial cells and analyzed effects on radiation-
induced epithelium damage at cell and tissue levels.
Fig. 6 Vascular endothelium mediates the radiation damage. a DIC microscopic views showing the villus morphology of the human Caco-2
intestinal epithelium cultured with and without human vascular endothelium under control conditions (Con) or after radiation exposure (Rad) (bar,
50 μm). b Quantiﬁcation of villus heights measured under the conditions described in a (n = 3; **P < 0.01; n.s. not signiﬁcant). c Representative
immunoﬂuorescence confocal micrographs of the Gut Chip device with the villus intestinal epithelium stained for epithelial tight junctions, ZO-1
(red) and intestinal mucin protein, MUC2 (green) (blue, DAPI-stained nuclei; bar, 50 μm). d Quantiﬁcation of ﬂuorescence intensities (a.u.) of MUC2
normalized per cell number under the conditions shown in c (n = 3; **P < 0.01, ***P < 0.001; n.s. not signiﬁcant)
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Interestingly, whereas Gut Chips containing both epi-
thelium and endothelium exhibited villus blunting in
response to radiation exposure (Fig. 4), there was no
signiﬁcant decrease in average height of villi in irradiated
chips lined by intestinal epithelium in the absence of
endothelium (Fig. 6a,b). We also found that the presence
of endothelial cells enhanced barrier function (reduced
permeability by ~10-fold; Supplementary Fig. S3c) and
increased mucus secretion (approximately fourfold;
Fig. 6c,d) by the epithelium compared to chips lacking
endothelium, and this was accompanied by suppressed or
delayed responses to radiation damage. For example, ROS
generation in irradiated epithelium was signiﬁcantly lower
when endothelium was not present (Supplementary
Fig. S3a,b). Moreover, in the absence of endothelium, no
changes in paracellular barrier function were observed
even as late as 24 h and 48 h after radiation (Supple-
mentary Fig. S3c). Thus, based on our observations, the
endothelium appears to be the principal target of intest-
inal radiation injury, which is consistent with recent
in vivo ﬁndings46.
Radio-protective effects of a potential radiation
countermeasure drug
Pharmacologic strategies for preventing or treating
radiation-induced intestinal injury are currently very
limited; however, a recent study showed that the pro-
lylhydroxylase inhibitor, DMOG, partially prevented
murine intestinal wall dysfunction when administered
before abdominal irradiation47. DMOG elevates levels of
HIF-1α and HIF-2α, which are known to promote cell
survival under conditions of stress, such as ionizing
radiation19,48. Similar to the in vivo ﬁnding, we found
that DMOG pre-treatment prevented cell detachment
(Fig. 5a-c), suppressed the increase in intestinal perme-
ability (Fig. 4d), increased MUC2 expression (Supplemen-
tary Fig. 5a,b), and reduced villus injury (Fig. 4e), as
evidenced by enhanced expression of ZO-1 (Fig. 5a)
and increased villus height (Fig. 4a,b) in irradiated Gut
Chips. In addition, we discovered that pre-treatment
of cells with DMOG signiﬁcantly reduced the number
of cells undergoing apoptosis in both the epithelium
and endothelium (Fig. 2b,c), in addition to inhibiting both
ROS generation (Fig. 3a,b) and lipid peroxidation (Fig. 3c,d)
in these cells. As expected this was associated
with increased expression of HIF-1α and HIF-2α (Supple-
mentary Fig. S4a-d), which is known to prevent ROS
generation49 as well as inhibit apoptosis50,51. Interestingly,
we also found that DMOG prevents DNA fragmentation
(Fig. 3e,f), which has never been described previously.
Thus, again, the human Gut Chip mimicked the protective
effects of this potential radiation countermeasure drug that
were previously observed in animal models of intestinal
inﬂammation51–53.
Discussion
In the present study, we leveraged a mechanically active,
microﬂuidic Gut Chip device to model human intestinal
radiation injury in vitro. The human Gut Chip recapitu-
lates clinically relevant acute radiation injuries at both
cellular and tissue–organ levels. Radiation induces loss of
junctional continuity, compromises intestinal barrier
function, and inhibits mucus production, in addition to
promoting villus blunting and distortion of microvilli. Our
data show that the endothelium appears to be more
sensitive to radiation injury in terms of ROS generation,
lipid peroxidation and DNA fragmentation, which ﬁrst
triggers rapid endothelial apoptosis that then appears to
trigger subsequent epithelial cell injury responses, as
previously described to in vivo14,33. Moreover, pre-
treatment with a potential MCM drug, DMOG, sig-
niﬁcantly reduced radiation toxicity in epithelium and
endothelium in this in vitro model, again mimicking
responses that have been previously observed in vivo47.
Because of the urgent need for predictive intestinal
radiation models, previous studies have explored the use
of other types of in vitro cultures, including organoids and
Transwell co-culture systems11,54. However, they were
found to be limited in their ability to replicate normal
human intestinal 3D architecture and function, and thus,
they could not recapitulate important features of radiation
responses, such as villus blunting, which have been
observed in human patients. Our results suggest that
these past models were ineffective because they failed to
recreate the physiologically relevant physical micro-
environment of the intestine, including ﬂuid ﬂow and
peristalsis-like mechanical deformations, which are pre-
sent in the human Gut Chip. Moreover, unlike our
experimental system, past in vitro models did not contain
human endothelial cells that are known to serve as key
contributors to radiation-induced intestinal dysfunc-
tion15,16. For example, using the vascularized human Gut
Chip, we found that the endothelium responds faster to
ionizing radiation compared to the epithelium, with
endothelial cells exhibiting an increase in apoptosis within
24 h after exposure, while epithelial cell death increased
over the following day. This is consistent with the past
ﬁnding that while exposure of mice to γ-radiation results
in loss of intestinal villi beginning approximately 24–36 h
after exposure, little apoptotic activity was observed in the
intestinal epithelium during the ﬁrst day12,55. Moreover,
when Gut Chips were lined by epithelium in the absence
of endothelium, we did not detect radiation-induced villus
blunting, loss of barrier function, or decreased mucus
secretion, conﬁrming that endothelial cells mediate the
intestinal radiation injuries as suggested by previous
in vivo studies15,16. In addition, we found out that
radiation-induced ROS generation by intestinal epithe-
lium cultured on-chip alone was signiﬁcantly lower than
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when it was co-cultured with endothelium. These data
suggest that enhanced ROS generation by the endothe-
lium may play a pivotal role in regulating intestinal
radiation damage, and hence that it could serve as a target
for therapeutics that mitigate radiation toxicity, as sug-
gested by recent in vivo reports25,46. Although radiation
damage is often coordinated by the intracellular actions of
ROS56, further investigation of other potential radiation-
mediators, such as inﬂammatory cytokines, are required
to fully understand the cross-talk between epithelial and
endothelial cells in response to radiation exposure.
In summary, the results we obtained are fully consistent
with past studies which revealed that the microvascular
endothelium is the initial target of radiation damage, and
that endothelial apoptosis is upstream of damage to the
intestinal epithelium33,35,57. Other studies have also
demonstrated that radiation-induced epithelial cell injury
and DNA damage are mediated via endothelial apoptosis
and ROS generation15,33–35, which trigger cytoskeletal
changes and structural alterations within the endothelial
cell monolayer58.
The changes in endothelial cell and tissue architecture
that we observed are consistent with the immediate
morphological hallmarks of radiation that have
been reported to occur in the vascular compartment in
patients at clinically relevant doses59,60. In addition, the
radiation-induced changes in the epithelium we observed
in the Gut Chip, ranging from villus blunting to distortion
of the tips of the villi to their complete villus, are con-
sistent with clinical ﬁndings in patients and animals
exposed to ionizing radiation37,61. A similar level of
damage to apical microvilli at the apical epithelial cell
surface also has been reported in both human and mouse
irradiated tissues36,62.
Importantly, we demonstrated that the Gut Chip
radiation model can be used to evaluate therapeutic
response of potential radiation countermeasure drugs. As
a proof-of-concept, we showed that DMOG, which is
known to protect murine intestine against radiation
damage by stabilizing HIF levels63, has similar effects in
the human Gut Chip. Interestingly, the radio-protective
effects of this drug on human cells and tissues have not
been previously reported, and thus, our ﬁndings provide
hope that this potential therapeutic approach could be
useful in humans. In addition to replicating effects of
DMOG previously observed at tissue and organ-level
in vivo47, our results also unveiled some novel features of
DMOG action at the cell level, including its ability to
prevent DNA fragmentation, which also has not been
previously described. In the future, our intestinal radiation
model could be harnessed to study the safety and efﬁcacy
of other radioprotectants that contain a free radical-
scavenging group, such as amifostine, which has been
reported to reduce DSB accumulation46,64.
We used the established human Caco-2 intestinal epi-
thelial cell line in the present study because it repro-
ducibly undergoes intestinal differentiation and exhibits
villi formation as well as transcriptional signatures remi-
niscent of the ileum when cultured within the mechani-
cally active Gut Chip model10,17,18. However, two
important caveats require consideration when interpret-
ing the results of this study with respect to the effects of
radiation on intestinal toxicity. The ﬁrst is that the Caco-2
cell line was originally isolated from a colon tumor, and
thus, while it can recapitulate many features of the human
ileum when analyzed at the transcriptional level18, it does
not fully express the phenotype of a normal human
intestine. These tumor-derived Caco-2 intestinal epithe-
lial cells also might differ in their sensitivity to radiation as
compared to normal epithelial and endothelial cells, so
further studies are required to fully elucidate the cross-
talk between the two tissue layers in response to radiation.
Speciﬁcally, this approach could be further strengthened
by integrating primary human intestinal epithelial cells
which might be more radio-sensitive into the model in the
future (e.g., by isolating cells from clinical biopsy sam-
ples), and this could enable one to evaluate patient-
speciﬁc responses to radiation as well. Second, while we
were capable of replicating multiple clinical responses of
intestinal epithelium and endothelium to radiation, other
cells, including immune cells and commensal microbiome
that are present within the intestinal microenvironment
are believed to play a pivotal role in small intestine
radiation toxicity in vivo65,66. Thus, it will be interesting to
explore how the presence of these other cell types in the
model might inﬂuence intestinal epithelial and endothelial
responses to radiation in the future.
When animals or humans are exposed to total body
radiation doses that lead to severe enterocyte depletion,
lethality is mainly due to the combined effect of endo-
thelial injury, GI damage, and bone marrow failure7.
Therefore, past studies focused on preventing GI damage
that utilized in vivo total body radiation models may
therefore have had limited clinical relevance46. In con-
trast, the human Gut Chip radiation model offers the
unique capability to analyze the direct effects of radiation
toxicity on cells and tissues within a single organ, in the
absence of contributions from other organs and systemic
factors. However, different vascularized human Organ
Chips can be linked by their common endothelium-lined
vascular channels to create an effective “human Body-on-
Chips”, which could then be used to explore how partial
or whole body exposure to radiation modiﬁes the
response of intestinal tissues contained within a linked
Gut Chip. Using this organ-level synthetic biology
approach, it should be possible to identify how individual
molecular, cellular, and physical factors contribute indi-
vidually and in combination to radiation toxicity. In
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addition to enabling study of the underlying mechanisms
involved in radiation-induced GI syndrome, the human
Gut Chip offers a potentially powerful tool for discovery
and screening of new and more effective countermeasure
drugs in the future.
Materials and methods
Human Gut-on-a-Chip microdevice
The microﬂuidic Gut-on-a-Chip devices were fabri-
cated from PDMS (SYLGARD® 184 silicone elastomer
kit) by soft lithography technique as previously repor-
ted17. The intestinal epithelium and vascular endothe-
lium channels shared same dimensions (1000 μm wide
× 14 mm long× 200 μm high) and separated by a porous
(10 μm diameter pores with 25 μm spacing) PDMS
membrane (50 μm high). Prior to cell seeding, both
microchannels were activated using oxygen plasma
(Diener ATTO; pressure, power, and plasma time were
0.5 mbar, 30W, and 2 min, respectively), functionalized
with (3-aminopropyl)trimethoxysilane (Sigma, 281778),
washed by ﬂowing absolute ethanol (Sigma, E7023) and
dried in a 80 oC oven. Microchannels were then coated
with type I collagen (30 μg ml−1; Gibco, A10483-01) and
Matrigel (100 μg ml−1; BD Biosciences, 356237) in the
serum-free Dulbecco’s Modiﬁed Eagle Medium (DMEM;
Gibco, 10564011) for 1 h at 37 oC. To form vascular
lumen, human endothelial cells (Human Umbilical Vein
Endothelial Cells (HUVECs); Lonza, C2519A (pooled
donor)) cultured in endothelial growth medium
(DMEM/F12 (Gibco, 11039-021) plus EGM-2 BulletKit
containing 100 U l−1 penicillin/100 mgml−1 streptomy-
cin (Pen/Strep; Gibco, 15140-122), hydrocortisone,
hFGF-B, VEGF, R3-IGF-1, ascorbic Acid, hEGF, GA-
1000, heparin, and 2% FBS; Lonza, CC-4176) were ﬁrst
introduced to the lower microchannel and incubated for
1 h to attach on bottom side of the channel. Afterwards,
HUVECs were seeded on the opposite side of the porous
membrane in the lower channel by immediate ﬂipping
the entire chip upside down and placing it in an incu-
bator for 1 h. The device was ﬂipped over again and
human intestinal epithelial cells (Caco-2 BBE human
colorectal carcinoma cell, Harvard Digestive Disease
Center) grown in DMEM (Gibco, 10564011) containing
Pen/Strep 20% Fetal Bovine Serum (FBS; Gibco, 10082-
147) were seeded (1.5× 105 cells cm−2) into the top
microchannel of the device and being allowed to adhere
statically for 1 h. Gut chip was then cultured statically in
incubator for an overnight to form monolayer. A day
after seeding, epithelial medium (DMEM/20%FBS/anti-
biotics) and endothelial medium with reduced FBS
(0.5%) were perfused at 60 μl h−1 through top and bot-
tom channels, respectively. To mimic peristalsis-like
motions, cyclic stretching (10% strain; 0.15 Hz)
was applied through vacuum chambers via a vacuum
controller 2 days after seeding. Five days after seeding,
villus intestinal epithelium spontaneously appeared in
top channel and endothelial vascular lumen formed in
bottom channel. Endothelium-free chips were similarly
prepared using the above procedure, except that after
coating the chips with ECM, they were seeded with
human intestinal epithelial cells (Caco-2) in top channel
without adding endothelial cells to the bottom channel.
Chip radiation
Gut-on-a-Chip microdevices containing villus intestinal
epithelium (with or without endothelium) were removed
from the syringe pump, immediately transferred to irra-
diation facility and exposed to a single 8 Gy dose of γ-
irradiation (Cs-137; Gammacell 40 Exactor) at 0.98 Gy
min−1. Temperature of irradiation chamber was kept at
37 °C through the procedure and no temperature ﬂuc-
tuations were observed. To treat the control chips simi-
larly, they were brought to irradiation facility and back
without being exposed to irradiation. To validate the
prophylactic effect of dimethyloxalylglycine (DMOG) in
our Gut-on-a-Chip devices, DMOG (Sigma, D3695)
reconstituted in UltraPure DNase/RNase-free distilled
water (Gibco, 10977015) and added to epithelium and
endothelium channels at 1 mM an overnight before irra-
diation procedure. Control chips (vehicle) received only
distilled water.
Morphological analyses
Morphological analyses were performed using at least
three independent gut chip samples at each interval,
where images of villi were taken at more than 10 different
locations. The intestinal villus morphology was evaluated
using differential interface contrast (DIC) microscopy
(Zeiss Axio Observer Z1 2, AXIO2). The villus micro-
architecture was also studied using immunoﬂoresencece
microscopy with a laser scanning confocal microscopes
(Leica SP5 X MP DMI-6000 and Zeiss TIRF/LSM 710)
inked to a 405-nm diode laser, a white light laser
(489–670 nm), or an argon laser (488 nm and 496 nm) and
coupled to a photo-multiplier tube or HyD detectors.
Acquired images were analyzed using IMARIS (MARIS
7.6 F1 workstation; Bitplane Scientiﬁc Software) and
ImageJ. High-resolution horizontal or vertical cross-
sectional images were obtained using deconvolution
(Huygens) followed by a 2D projection process.
For SEM analysis, gut chips were designed in a way that
top channel was not irreversibly bonded to the mem-
brane, which permitted the device to be dismantled
manually without disturbing the cultured cells. Cells were
ﬁxed with paraformaldehyde (PFA, 4%; Electron Micro-
scopy Sciences, 157–4) and glutaraldehyde (2.5%; Sigma,
G7776) and incubated in osmium tetroxide (0.5%; Elec-
tron Microscopy Sciences, 19152) before serial
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dehydration in ethanol. Samples were then dried using
hexamethyldisilazane (Electron Microscopy Sciences,
999-97-3) and imaged with a ﬁeld emission SEM (Tescan
Mira GMU, Czech Republic).
Paracellular permeability measurements
To measure intestinal permeability, 50 μgml−1 of cas-
cade blue (5.9 kDa; ThermoFisher, C687) were introduced
to the top channel of the chips at 60 μl h−1 and ﬂuores-
cence intensity of top and bottom channel efﬂuents at
excitation/emission wavelengths of 390 nm/420 nm were
measured using a multi-mode plate reader (BioTekNEO)
at different intervals. Apical-to-basolateral ﬂux of the
paracellular marker was calculated according to the fol-
lowing equation: Papp= (dQ/dt)/A×dC, where Papp (cm
s−1) denotes the apparent permeability coefﬁcient, dQ/dt
(g s−1) is the molecular ﬂux, A (cm2) is the total area of
diffusion, and dC (mgml−1) is the average gradient.
Detection of reactive oxygen species and lipid
peroxidation
Immediately after irradiation procedure, cellular ROS,
and LPO were detected using CellROX Green (Life
Technologies, C10444) and Image-iT Lipid Peroxidation
Kit (Life Technologies, C10445), respectively, according
to the manufacturer’s protocol. The signal intensity
of intracellular levels of ROS was measured at excitation/
emission wavelengths of 485 nm/520 nm (green),
and ratios of emission peak from the 590 nm (red) to 510
nm (green) were used to quantify lipid peroxidation in
chips.
Cellular toxicity and apoptosis
LDH activity assay: CytoTox 96 non-radioactive
cytotoxicity assay (LDH; Promega, G1780) was used
according to the manufacturer’s instructions to measure
epithelium and endothelium death rate at different
intervals after irradiation procedure and DMOG treat-
ments. In brief, efﬂuents were collected from top and
bottom channels, mixed with LDH substrate reagent and
incubated for 30 min. The enzymatic reaction was ter-
minated using stop solution (containing acetic acid) and
the absorbance at 492 nm was recorded using a multi-
mode plate reader (BioTekNEO). The LDH activity was
assessed using quadruplicate of each group, calculated
after subtracting the background absorbance values and
reported as a fold change of the total LDH values of
control group.
TUNEL assay: Late apoptosis was evaluated by the
terminal deoxynucleotidyl transferase-mediated dUTP-
biotin nick-end labeling (TUNEL) immunostaining using
Click-iT TUNEL Alexa Fluor Assay Kit (Invitrogen,
C10247) according to the manufacturer’s protocol. Chips
were co-stained with DAPI (Invitrogen, D1306) as the
nuclear DNA marker and the apoptotic cells were coun-
ted from 20 different ﬁelds (ﬁve ﬁelds each from four
replicates) to get an average number of TUNEL-positive
cells per ﬁeld.
Immunoﬂuorescence microscopy
For immunoﬂuorescence staining, cells in both channels
were ﬁrst gently washed with PBS, then ﬁxed with PFA
(4%; Electron Microscopy Sciences, 157–4) for 20min and
subsequently washed with additional PBS. Cells were then
permeabilized with 0.25% Triton X-100 (0.25%; Sigma,
T8787) for 20 min and incubated with blocking buffer
containing 1% BSA (Sigma, A4503) and 10% donkey
serum (Sigma, D9663) for 30min at room temperature.
Cells were then incubated with antibodies directed against
ZO-1 (Life Technologies, 33-9100, dilution 1:200),
PECAM-1/CD31 (eBioscience, BMS137, dilution 1:100),
VE-cadherin/CD144 (BD Biosciences, 555661, dilution
1:200), Villin (Life Technologies, PA5-29078, dilution
1:100), 53BP1 (Abcam, ab36823, dilution 1:100), MUC2
(Santa Cruz Biotechnology, sc-15334, dilution 1:100), or
HIF-1α (Abcam, ab16066, dilution 1:100) overnight at
4 oC, followed by 6× 5min PBS washes. Secondary anti-
bodies (Life Technologies) were then introduced in the
channels for 1 h at room temperature and washed three
times with PBS. Cells were co-stained with DAPI (Invi-
trogen, D1306). Microscopy was performed with a laser
scanning confocal microscopy (Leica SP5 X MP DMI-
6000 or Zeiss TIRF/LSM 710). Quantiﬁcation of the
immunoﬂuorescence images was performed using ImageJ
software based on the mean ﬂuorescence intensity on a
per cell basis.
Western blot
To perform Western blot analysis, cell lysates were
obtained using RIPA (Alfa Aesar, J63306) buffer supple-
mented with protease inhibitor cocktail (Roche). Followed
by SDS-PAGE fractionation, samples were transferred to a
nitrocellulose membrane according to the manufacturer’s
protocol (BioRad). Westerns were run using precast gra-
dient gels (4–15%, Biorad), with the same amount of
protein load in each lane of an individual gel, and the
relevant protein ranges were cut out and blotted with the
individual antibodies. After blocking the membranes with
5% non-fat milk in TBST (50 mM Tris-HCl, 150mM
NaCl, 0.1% Tween-20), samples were incubated with
antibodies against HIF-1α (R&D Systems, MAB1536,
dilution 1:500), HIF-2α (Abcam, ab73895, dilution 1:500)
and GAPDH (Santa Cruz Biotechnology, sc-32233, dilu-
tion 1:500). A horseradish-peroxidase-conjugated goat
anti-rabbit or -mouse antibody was then added, and the
membranes were developed with the ECL Plus system
(GE Healthcare) according to the manufacturer’s
protocol.
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Statistical analysis
All experiments were carried out at n= 3–6 (see ﬁgure
captions), and results and error bars in this article are
presented as mean± standard error of the mean (s.e.m).
Data analysis was performed with a one-way analysis of
variance with Tukey HSD post hoc tests, using Graphpad
Prism software. Statistical analysis between two condi-
tions was performed by an unpaired Student’s t test. P
values of less than 0.05 were considered to be statistically
signiﬁcant (*P< 0.05, **P< 0.01, ***P< 0.001).
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